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drive weak gene expression (5). Sequence analysis of these two
genes suggests that they belong to the basic helix-loop-helix
(bHLH) family of transcriptional activators (15, 20). Consistent with this observation, the products of the INO4 and INO2
genes form a heterodimer that binds to a canonical bHLH
binding site termed the UASINO element (C/AATGTGAAAT)
(3, 27). The first six base pairs of this element contain the
canonical bHLH binding site (5⬘ CANNTG 3⬘) (1). The
UASINO element is found in the promoters of the coordinately
regulated phospholipid biosynthetic genes INO1, CHO1,
CHO2, and OPI3 (9). Transcription of these genes is derepressed when inositol and choline are absent from the growth
medium and repressed in the presence of inositol and choline.
The UASINO element is both necessary and sufficient to confer
inositol-and-choline-mediated regulation (6, 17, 25).
Ino2p contains a transcriptional activation domain, which
can activate a reporter gene when artificially tethered to DNA
(27). On the other hand, it has been suggested that Ino4p
cannot activate transcription on its own (27). This suggests that
Ino4p is responsible for recruiting Ino2p to the UASINO element that enables the transcriptional activation domain of
Ino2p to activate transcription of the phospholipid biosynthetic
genes. Strains containing mutant alleles of INO2 or INO4 are
unable to derepress INO1 expression, resulting in inositol auxotrophy (9, 13). Repression of the phospholipid genes in response to inositol-and-choline supplementation is mediated by
the OPI1 gene, which encodes a leucine zipper protein. Strains
containing a mutant allele of the OPI1 gene overexpress INO1,
resulting in an overproduction-and-excretion-of-inositol phenotype (Opi⫹) (14).
A previous study showed that an INO2-cat reporter gene is
regulated by inositol and choline (5). Addition of inositol and
choline repressed INO2-cat gene expression 12-fold. This regulation required both the INO2 and INO4 genes, showing that
INO2 is regulated in the same manner as the phospholipid
biosynthetic genes. However, an INO4-cat gene was expressed
constitutively with respect to inositol and choline and did not
require the INO2 gene (5). This suggested that the mechanism

Transcriptional regulation is a mechanism, in many organisms, by which to coordinate the expression of multiple genes
in response to various cellular conditions. Specific cis and trans
elements mediate the control of transcription. In Saccharomyces cerevisiae, an upstream activating sequence (UAS) located
within 1,400 bp of the translational start site dictates the binding of activator proteins (11). Once bound to the UAS element, activator proteins interact with the general transcriptional machinery located at the TATA box (⫺60 to ⫺120 bp).
Therefore, it is the interactions between promoter elements
and transcription factors that direct the timing and strength of
gene expression. However, much of what is known about yeast
promoters comes from studies of genes expressed in easily
detectable quantities. With the complete genome sequence
available and the advent of genome-wide approaches to the
study of gene expression, it is becoming clear that there are a
large number of weakly expressed genes that play an important
role in the regulation of various processes in yeast. However,
little is known about the cis and trans elements necessary for
weakly expressed genes, although it is clear from studies on the
GAL4 promoter that novel cis-acting elements are required for
expression. For example, studies on the GAL4 promoter have
identified an upstream essential sequence element that is required for basal transcription but is not interchangeable with a
TATA element (10). Here we present an analysis of the INO4
promoter to further our understanding of the cis-acting elements necessary for weak promoter expression.
In S. cerevisiae, transcriptional regulation of the phospholipid biosynthetic genes is mediated by the INO4 and INO2
genes (9). Low levels of chloramphenicol acetyltransferase
(CAT) activity from INO4-cat and INO2-cat promoter fusions
places these genes into a small group of yeast promoters which
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In Saccharomyces cerevisiae, the phospholipid biosynthetic genes are transcriptionally regulated in response
to inositol and choline. This regulation requires the transcriptional activator proteins Ino4p and Ino2p, which
form a heterodimer that binds to the UASINO element. We have previously shown that the promoters of the
INO4 and INO2 genes are among the weakest promoters characterized in yeast. Because little is known about
the promoters of weakly expressed yeast genes, we report here the analysis of the constitutive INO4 promoter.
Promoter deletion constructs scanning 1,000 bp upstream of the INO4 gene identified a small region (ⴚ58 to
ⴚ46) that is absolutely required for expression. S1 nuclease mapping shows that this region contains the
transcription start sites for the INO4 gene. An additional element (ⴚ114 to ⴚ86) modestly enhances INO4
promoter activity (fivefold). Thus, the region required for INO4 transcription is limited to 68 bp. These studies
also found that INO4 gene expression is not autoregulated by Ino2p and Ino4p, despite the presence of a
putative UASINO element in the INO4 promoter. We further report that the INO4 steady-state transcript levels
and Ino4p levels are regulated twofold in response to inositol and choline, suggesting a posttranscriptional
mechanism of regulation.
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TABLE 1. Oligonucleotides used in this study
INO4-BamHI (0)

5⬘-GGGGGGATCCTATTGCTTTTCTCTT-3⬘

controlling INO4 expression might be different from that of the
phospholipid biosynthetic genes and the INO2 gene.
In the present study, we set out to define the cis elements
necessary for INO4 gene expression. We identified two elements of the INO4 promoter that are necessary for full expression. One of these elements maps to the same region as the
transcriptional start site. We also found that expression of the
native INO4 gene, and its protein product, is modestly regulated by inositol and choline. Our INO4-cat reporter gene
fusions suggest that this regulation does not occur at the level
of transcription initiation.
MATERIALS AND METHODS
Strains and growth conditions. The yeast strains used in this study were
BRS1001 (MATa ade2-1 his3-11,15 leu2-3, 112 can1-100 ura3-1 trp1-1), BRS2001
(MATa ade2-1 his3-11,15 leu2-3,112 can1-100 ura3-1 trp1-1 ino2⌬::TRP1),
BRS2004 (MAT␣ ade2-1 his3-11,15 leu2-3,112 can1-100 ura3-1 trp1-1
ino4⌬::LEU2), BRS2005 (MATa ade2-1 his3-11,15 leu2-3,112 can1-100 ura3-1
trp1-1 opi1⌬::LEU2), Null20 (MATa his3-11,15 leu2-3,112 ura3-1 ino4⌬::LEU2),
SH307 (MAT␣ his3-11,15 leu2⌬1 ura3-52 ino4⌬::LEU2), and YB588 (MATa ade2
ade3 his3 leu2 ura3 trp1 nmt1-451D ino4⌬::HIS3). All cultures were grown at
30°C in synthetic medium either supplemented with 75 M inositol and 1 mM
choline or lacking inositol and choline (16).
Plasmid constructions. A nested set of INO4 promoter deletions to be fused
to the cat reporter gene was created by PCR using appropriate primers (Table 1).
The 5⬘-terminal deletion PCRs used the 3⬘ primer INO4-BamHI along with the
5⬘ primers INO4-1000 through INO4-E3 (Table 1). The 3⬘-terminal promoter
deletions used the 5⬘ primer INO4-A along with the 3⬘ primers INO4-F through
INO4-I. The individual PCR products were inserted into pGEM-T (Promega,
Madison, Wis.). Each deletion fragment was excised from the pGEM-T derivative by digestion with BglII and BamHI and inserted into pBM2015 (10). The
pBM2015 derivatives were transformed into yeast as previously described (5).
Plasmids derived from YCp50 were used to test the various promoter deletions
for the ability to direct INO4 expression. PCR was performed using the various
5⬘ deletion primers with the 3⬘ primer INO4-3⬘ to create the nested set of
promoter deletions upstream of the entire INO4 open reading frame (ORF).
These PCR products were cloned into the pGEM-T vector. SalI-SphI fragments
were isolated from the pGEM-T derivatives and cloned into YCp50.
A YCp50-INO4-HA construct was created by mutational PCR. PCR was used
to introduce a BglII site three codons into the INO4 ORF. To do this, a PCR
using the primers INO4-3⬘ and INO4-HA 5⬘ created an 851-bp product containing the INO4 ORF and a 5⬘ BglII site. A second PCR with the primers INO4-A
and INO4-HA 3⬘ created a 500-bp product containing the INO4 promoter and a
3⬘ BglII site. The PCR products were digested with BglII and ligated to create a
product which contained the INO4 promoter and ORF with a BglII site immediately downstream of the start codon. The ligated fragment was used as a
template for another round of PCR containing the primers INO4-A and INO43⬘, resulting in a 1,350-bp product. This PCR fragment was cloned into pGEM-T.
The pGEM-T derivative was partially digested with BglII, and a 120-bp BglII
fragment containing three tandem copies of the hemagglutinin (HA) epitope

(provided by Susan Henry, Carnegie Mellon University) was inserted. A SalISphI fragment was isolated from the pGEM-T derivative and cloned into YCp50.
All promoter constructs and the YCp50-INO4HA construct was confirmed by
DNA sequencing. The plasmid pTA-INO4 contains the entire INO4 ORF, starting at the translational initiator codon and extending past the translational stop
codon.
CAT assays. Five-milliliter cultures were grown to 50 to 60 Klett units in
appropriate media. Assays were conducted as previously described (5). Units of
CAT activity were defined as counts per minute measured in the organic phase
and expressed as a percentage of the total counts per minute (percent conversion) divided by the amount of protein assayed (in micrograms) and the time of
incubation (in hours).
RNA analysis. RNA was isolated from yeast by a glass bead disruption and hot
phenol extraction procedure (8). RNA probes (cRNA) for Northern (RNA)
hybridizations were synthesized with the Gemini II Core System (Promega,
Madison, Wis.) from plasmids linearized with a restriction enzyme and transcribed with an RNA polymerase as follows (shown as plasmid, restriction enzyme, RNA polymerase) for the probe indicated in parentheses: pTA-INO4,
SalI, T7 (INO4); pJH310, HinDIII, T7 (INO1); and pAB309⌬, EcoRI, SP6
(TCM1). Northern hybridizations were performed as previously described (14),
results were visualized by autoradiography, and gene-specific counts per minute
were quantitated using a Betascope 603 Blot Analyzer (Beta-gen, Waltham,
Mass.).
For the S1 nuclease digestion assay, BRS1001 transformed with pJA201 (contains the entire INO4 gene) and BRS2004 were grown in the appropriate media.
RNA was isolated as described above. A single-stranded probe was created using
asymmetric PCR (12). A standard 100-l PCR mixture contained 1 g of the
INO4-PE oligonucleotide and 0.3 ng of the INO4-A oligonucleotide. The singlestranded PCR product was purified by gel electrophoresis and labeled at the 5⬘
terminus with [␥-32P]ATP using T4 polynucleotide kinase (Gibco BRL, Grand
Island, N.Y.) (22). Approximately 10 ng of labeled probe was coprecipitated with
20 g of total yeast RNA. The pellet was resuspended in 10 l of S1 hybridization buffer [80% formamide, 0.4 M NaCl, 0.04 M piperazine-N,N⬘-bis(2-ethanesulfonic acid) (PIPES; pH 6.6), 0.1 mM EDTA]. The hybridization reaction was
overlaid with mineral oil, denatured at 95°C for 3 min, and hybridized overnight
at 46°C. Next, 300 l of S1 digestion buffer (0.28 M NaCl, 0.03 M sodium acetate
[pH 4.5], 4.5 mM ZnCl2, salmon sperm DNA at 20 g/ml, S1 nuclease at 1,200
U/ml (Boehringer Mannheim, Indianapolis, Ind.) was added and the reaction
mixture was incubated at 15°C for 1 h. The digestion reaction was terminated by
addition of 50 l of 2.5 M ammonium acetate–50 mM EDTA. The reaction
mixture was then extracted with an equal volume of phenol-chloroform-isoamyl
alcohol (25:24:1), and the digestion products were precipitated. The pellet was
resuspended in 10 l of gel loading dye (10 mM NaOH, 95% formamide, 0.05%
bromophenol blue, 0.05% xylene cyanol), denatured at 95°C for 5 min, and
fractionated through a 4% denaturing polyacrylamide gel. A sequencing ladder
generated using the INO4-PE primer was used as the standard.
Western blots. Preparation of whole-cell extracts of S. cerevisiae was performed as previously described (18), and 50 g of yeast extract was separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were transferred to nitrocellulose by electroblotting at 150 mA for 2 h. The blot was stained
with Ponceau to confirm equal loading and transfer of proteins. The blot was
incubated in BLOTTO (100 mM Tris, 1.5 M NaCl, 0.5% Tween 40, 5% powder
milk) overnight at 4°C with constant shaking. Anti-HA antibody (Boehringer
Mannheim) was added to a final dilution of 1/250 and incubated for 1 h at room
temperature with shaking. The blot was then washed in BLOTTO five times for
5 min each time. An alkaline phosphatase-conjugated anti-immunoglobulin G
antibody (Zymed Laboratory Inc., San Francisco, Calif.) was added to BLOTTO
at a final dilution of 1/1,000 and incubated for 1 h at room temperature. The blot
was washed in BLOTTO five times for 5 min each time. The blot was suspended
in alkaline phosphate buffer (100 mM Tris, 100 mM NaCl, 5 mM MgCl2).
Nitroblue tetrazolium–5-bromo-4-chloro-3-indolylphosphate (BCIP) (Promega)
was added in a 2:1 ratio to the buffer and allowed to react for 1 h. The reaction
was stopped by the addition of stop buffer (200 mM Tris [pH 8.0], 5 mM EDTA).

RESULTS
Previous results obtained by using an INO4 promoter fusion
to the cat reporter gene suggested that INO4 expression is
unresponsive to inositol and choline (5). Until this report, we
had been unable to detect the INO4 transcript using Northern
blot hybridization. In part, this is due to the low abundance of
the INO4 transcript, which was overcome by generating a highspecific-activity cRNA probe. In addition, the INO4 sequences
included in the probe itself are also important since the ORF
and 3⬘ untranslated region are required. Probes containing the
INO4 ORF or parts of the ORF are not sufficient to detect the
INO4 transcript (J. M. Lopes, unpublished data). To determine if the INO4-cat reporter accurately reflected expression
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INO4-1000 .....................5⬘-AGATCTGATGCATCGCCGACC-3⬘
INO4-750 .......................5⬘-AGATCTTGGATTATAGTTGTT-3⬘
INO4-A (⫺496) ............5⬘-GGGGAGATCTAAGCTTTAGTGTCGA-3⬘
INO4-B (⫺396).............5⬘-AGATCTTGTAGTCCAAGCCAG-3⬘
INO4-C (296)................5⬘-AGATCTTTTAGTAGCATCAGG-3⬘
INO4-D (⫺186) ............5⬘-AGATCTGATTAGTCGTCTTCT-3⬘
INO4-UAS (⫺125).......5⬘-AGATCTTATTCACATGTTTTTC-3⬘
INO4-E (⫺114) ............5⬘-AGATCTTTTTTCTCACCTTAA-3⬘
INO4-E1 (⫺86) ............5⬘-AGATCTTTGCCTTTGCGAAAT-3⬘
INO4-E2 (⫺58) ............5⬘-AGATCTAGATAAGCTTGACGA-3⬘
INO4-E3 (⫺30) ............5⬘-AGATCTGCGGCTTGAACTAAA-3⬘
INO4-F (⫺46)...............5⬘-GGATCCGTCAAGCTTATCTTG-3⬘
INO4-G (⫺186) ............5⬘-GGATCCTATTTATAACAAAGA-3⬘
INO4-H (⫺201) ............5⬘-GGATCCTATTTGTTCACTATA-3⬘
INO4-I (⫺346)..............5⬘-GGATCCGGAGATCCTTGTACA-3⬘
INO4-3⬘..........................5⬘-CCCGGGTTAATTGTT-3⬘
INO4-HA 5⬘ ..................5⬘-ATGACGAAAGATCTTAAGGAGATACAA-3⬘
INO4-HA 3⬘ ..................5⬘-TATCTCCTTAAGATCTTTCGTCATTAT-3⬘
INO4-PE........................5⬘-GCCAGTTCACCCTTTATCTCC-3⬘
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of the native INO4 gene, steady-state transcript levels were
quantitated by Northern blot hybridization. RNA was isolated
from strains grown in medium that normally represses (with 75
M inositol and 1 mM choline), partially derepresses (with 10
M inositol and 1 mM choline), or completely derepresses
(lacking inositol and choline) most of the phospholipid biosynthetic structural genes (9, 13). An INO4-specific cRNA probe
recognized a single major RNA of approximately 600 nucleotides (Fig. 1A). Quantitation of this transcript revealed that
steady-state INO4 levels are reduced by 60% in a wild-type
strain in response to inositol-and-choline supplementation
(Fig. 1B). Repression of the phospholipid biosynthetic genes in
response to inositol and choline is known to require the negative regulatory protein encoded by OPI1. Like the phospholipid biosynthetic genes, the 60% reduction of INO4 expression
by inositol and choline is dependent on a wild-type allele of
OPI1. However, unlike the phospholipid biosynthetic genes,
regulation of INO4 by inositol and choline does not require a
functional copy of INO2 (9) (Fig. 1A and B). To ensure that
the ino2⌬ strain lacked the INO2 gene function, we quantified
expression of the INO1 transcript. As expected, INO1 expression was eliminated in the ino2⌬ mutant strain (Fig. 1C).
It is interesting that the modest regulation of steady-state
INO4 levels in response to inositol and choline was not observed with the INO4-cat reporter gene (5). One possible explanation for this difference is that promoter sequences absent
from the INO4-cat reporter gene are required for the response
to inositol and choline. The original INO4-cat gene contained
500 bp of the INO4 promoter (5). To ensure that all of the
potential promoter elements were included, two additional
INO4-cat constructs were created that contained 750 and 1,000
bp upstream of the INO4 translational start site. However,
these constructs also failed to exhibit a response to inositoland-choline supplementation (Fig. 2). It seems unlikely that
the INO4 promoter would encompass sequences farther upstream than 1,000 bp, since this would include most of a divergent ORF, YOL107W. The lack of regulation of the INO4cat gene suggests that INO4 expression may be regulated at the
level of mRNA stability by inositol and choline. This possibility
was explored in greater detail as described below.
The possibility that inositol and choline may also exert regulation at the level of mRNA stability prompted us to examine
Ino4p levels under repressing and derepressing conditions. Toward this end, we tagged Ino4p at the N terminus with three
tandem copies of the HA epitope. This fusion was inserted into
the YCp50 (YCp50-INO4HA) vector and subsequently transformed into an ino4⌬ mutant strain (BRS2004). Yeast extracts
were prepared from strains transformed with either YCp50INO4 or YCp50-INO4HA grown in medium that normally
represses and derepresses the phospholipid biosynthetic genes.
Western blotting using an anti-HA antibody revealed that
Ino4p protein levels are decreased in the presence of inositol
and choline (Fig. 3). This result is consistent with the steadystate INO4 mRNA levels.
Transcriptional regulation of the phospholipid biosynthetic
genes and the INO2 regulatory gene is dependent on both the
INO2 and INO4 genes. However, INO4 transcription does not
require INO2 (Fig. 1A and B). This is consistent with a previous report showing that expression of an INO4-cat promoter
fusion did not require the INO2 gene (5). Genes that are
responsive to inositol and choline are typically dependent on
both the INO2 and INO4 genes for derepression. However,
some genes have been found which require INO4 but not INO2
for their expression (9). In fact, this laboratory and others have
reported that INO4-cat and INO4-lacZ reporter gene expression does not require INO2 but does require INO4 (5, 26).

J. BACTERIOL.

FIG. 1. Quantitative analysis of INO4 and INO1 mRNAs. (A) Representative Northern blot hybridization showing INO4 transcript levels. TCM1, a constitutively expressed ribosomal protein gene, was used to normalize for loading
variations. The relevant genotypes of the strains used are shown in parentheses.
(B) Bar values represent ratios of INO4 to TCM1 counts per minute quantified
using a Betascope 603 Blot Analyzer (Beta-gen). (C) Bar values represent ratios
of INO1 to TCM1 counts per minute. Cells were grown in complete synthetic
medium supplemented with 75 M inositol and 1 mM choline (I⫹75C⫹) or 10
M inositol and 1 mM choline (I⫹10C⫹) or lacking inositol and choline
(I⫺C⫺). The values shown are averages of at least three separate trials and are
normalized to that of the wild type without inositol and choline (100%).
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Surprisingly, in the present study, we observed that the level of
CAT activity in an ino4⌬ strain (BRS2004) was equivalent to
that in the wild-type strain, suggesting that INO4 is not required for INO4-cat expression (Fig. 2).
An explanation for this difference presented itself when we
noticed that in the earlier study we had employed a different
ino4⌬ strain, Null20 (5). Curiously, Null20 and BRS2004 both
originated as ino4⌬ mutant spores isolated from the same
tetrad and are predicted to be isogenic (J. Ambroziak, personal
communication). To determine if the two ino4⌬ strains behaved differently, we retransformed the INO4-cat construct
into the Null20 strain and assayed for CAT activity. As seen in
the earlier report, no CAT activity was observed in the Null20
transformants. Therefore, the discrepancy lay within the ino4⌬
strains. One of the strains may have obtained a second mutation that alters expression of the INO4-cat reporter. To determine the correct INO4-cat phenotype, we assayed for CAT
activity in two additional, independently isolated ino4⌬ mutant

FIG. 3. Western blot analysis of HA-tagged Ino4p. This representative Western blot shows Ino4p levels in cells grown in complete synthetic medium either
lacking (⫺) or supplemented with (⫹) 75 M inositol and 1 mM choline.

strains with entirely different genetic histories: SH307 (kindly
provided by Miriam Greenberg, Wayne State University) and
YB588 (kindly provided by Steven Cok, Washington University) The CAT expression levels in these two strains were
comparable to the levels in strain BRS2004. We measured
INO4-cat expression in multiple ino4⌬ strains and found the
following mean levels of CAT activity (⫾ the standard deviations): BRS2004, 4.75 ⫾ 0.14 U; SH307, 2.97 ⫾ 0.53 U; YB588,
3.15 ⫾ 0.84 U; Null20, 0.02 ⫾ 0.01 U. These results support the
conclusion that INO4 is not autoregulated.
Transcriptional regulation of the phospholipid biosynthetic
genes, and the INO2 regulatory gene, in response to inositol
and choline is mediated by a UASINO element. The INO4
promoter contains two putative bHLH binding sites, with the
proximal bHLH binding site resembling a UASINO element.
This prompted us to delineate the region(s) of the INO4 promoter that is required for gene expression. To do this, we
created a nested set of INO4 promoter deletions fused to the
cat reporter gene. The constructs were integrated at the GAL4
locus in single copy, and all integrations were confirmed by
Southern blotting. Cultures were grown in media with or without both inositol and choline and assayed for CAT activity.
This assay demonstrated that the ⫺86 to ⫺46 region of the
INO4 promoter is required to drive expression of the cat gene
in an inositol-and-choline-independent manner (Fig. 2). As
shown above, expression from the complete INO4 promoter
does not require INO2 or INO4 (Fig. 2). However, the possibility remained that elements within the promoter require
INO2 and INO4 to maintain appropriate INO4 expression levels. Therefore, the promoter deletions were assayed in ino2⌬
and ino4⌬ mutant strains under completely repressing conditions. The results confirmed that the ⫺86 to ⫺46 region of the
INO4 promoter is necessary and sufficient for INO4 expression
(Fig. 2). This also demonstrated that the two putative bHLH
binding sites within the INO4 promoter are not functional and
not dependent on the INO2 and INO4 genes.
Because it is possible that integration of the INO4-cat constructs at the GAL4 locus could artificially alter expression of
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FIG. 2. Expression of INO4-cat fusions in the wild type (WT) (BRS1001), ino4⌬ (BRS2004), and ino2⌬ (BRS2001) strains. Transformants containing the various
promoter deletions were grown in uracil-lacking synthetic medium either containing 75 M inositol and 1 mM choline (I⫹C⫹) or lacking inositol and choline (I⫺C⫺).
Extracts from the yeast transformants were prepared and assayed for CAT activity. The values shown are averages of at least three separate trials. YOL107W is a
divergent ORF. The locations of two putative bHLH binding sites and a potential TATA box are shown. N.D., not determined.

2750

ROBINSON AND LOPES

J. BACTERIOL.

FIG. 4. Complementation of ino4⌬ (BRS2004) inositol auxotrophy by various YCp50-INO4 promoter deletions. Respective transformants were plated on
uracil-lacking synthetic medium containing inositol and choline and replica
plated to uracil-lacking synthetic medium also lacking inositol and choline.
Growth is indicated by a plus sign, and absence of growth is indicated by a minus
sign. Quantitation of steady-state INO1 mRNA transcript levels by Northern blot
hybridization in the wild-type strain (BRS1001) and an ino4⌬ mutant strain
(BRS2004) transformed with the YCp50-INO4 promoter deletion constructs is
shown. Strains were grown in uracil-lacking synthetic medium either containing
75 M inositol and 1 mM choline (I⫹C⫹) or lacking inositol and choline
(I⫺C⫺). TCM1 was used to normalize for loading variations. The values shown
represent ratios of INO1 to TCM1 expression levels. The locations of two putative bHLH binding sites and a potential TATA box are shown as in Fig. 2.

the INO4-cat gene, we assayed for the ability of the INO4
promoter deletions to drive expression of the INO4 gene. PCR
products that contained the various promoter deletions upstream of the entire INO4 ORF were created. The PCR products were ligated into the YCp50 vector and transformed into
ino4⌬ mutant strain BRS2004. Expression of the INO4 gene
from the various promoter deletions resulted in complementation of the inositol auxotrophy of BRS2004. This assay provided further proof that the ⫺58 to ⫺46 region of the INO4
promoter is absolutely required to express INO4 at levels sufficient to complement the inositol auxotrophy of an ino4⌬
mutant strain (Fig. 4).
Placement of the deletion constructs on a centromeric plasmid may cause overexpression of the INO4 gene. This may
alter the regulation of the INO1 gene, potentially leading to
the abnormal expression of INO1. To address this issue, we
measured the steady-state INO1 transcript levels in these
strains by Northern blot hybridization. The regulation of INO1
transcript levels in the transformants was comparable to the
regulation observed in a wild-type strain (compare Fig. 4 to
Fig. 1C).
To aid in the interpretation of the promoter deletion studies,

FIG. 5. S1 nuclease digestion assay of INO4 mRNA. A single-stranded PCR
probe was hybridized to total cellular mRNA from the wild type (WT) strain
(BRS1001) transformed with pJA201, and an ino4⌬ mutant strain (BRS2004).
BRS1001 was grown in leucine-lacking synthetic medium containing 75 M
inositol and 1 mM choline, while BRS2004 was grown in complete synthetic
medium containing 75 M inositol and 1 mM choline. S1 digestion fragments
were run on a denaturing polyacrylamide gel next to the INO4 sequence that was
generated with the same primer used to synthesize the probe. Different exposures of the sequencing ladder (1 day) and S1 digestion products (4 days) are
shown. Nucleotide assignment of INO4 mRNA start sites. The stippled box
represents the major start site. The solid boxes represent minor start sites.
Sequences refer to the exact nucleotides present in the respective promoter
deletions.
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we mapped the INO4 transcriptional start site using an S1
nuclease assay. However, native INO4 expression levels were
too low to be detected by this assay. Therefore, wild-type strain
BRS1001 was transformed with pJA201, a multicopy plasmid
containing the entire INO4 gene driven by its own promoter
(2). Overexpression of the INO4 gene in this transformed
strain allowed detection of the INO4 initiation sites. The assay
revealed one major start site at ⫺48 and two additional minor
transcript start sites at ⫺54 and ⫺47 (Fig. 5). Therefore, the
transcriptional start sites of INO4 fall within the minimal region of the promoter required for expression as defined by the
INO4-cat deletion studies and the YCp50-INO4 derivatives.
The INO4-cat promoter deletion studies also identified a
potential regulatory element. Deletion of the region from
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⫺114 to ⫺86 resulted in a 5- to 10-fold decrease in cat expression from the INO4 promoter (Fig. 2). Yet, the YCp50 derivatives containing INO4 promoter sequences to ⫺86 and ⫺58
were still able to complement the inositol auxotrophy of
BRS2004 (Fig. 4). This suggested that in spite of the 5- to
10-fold decrease in INO4, as seen in the CAT assay, there is
sufficient Ino4p present to regulate its target genes.
DISCUSSION

expressed (1). Therefore, it is Myc and Mad concentrations
that are rate limiting for heterodimer formation and ultimately
responsible for determining which cell program is expressed.
The similarity between the sequence and expression of Ino4p
and Max suggests that Ino4p, like Max, may bind other bHLH
proteins in yeast. Results of a two-hybrid study suggest that this
is, in fact, true (K. A. Robinson and J. M. Lopes, unpublished
data). By binding to bHLH proteins other than Ino2p, it is
possible that Ino4p is responsible for regulating genes other
than the phospholipid biosynthetic genes. Results obtained by
using a whole-genome array suggest that there are genes independent of the phospholipid biosynthetic genes, which are
each regulated positively and negatively by INO4 (Robinson
and Lopes, unpublished data). Therefore, the INO4 pattern of
expression suggests that it is a housekeeping gene in yeast.
A previous report from this laboratory (5) and data presented here (Fig. 2) showed that the INO4-cat construct is
expressed constitutively. Another report using INO4-lacZ suggested that INO4 is autoregulated in response to inositol and
choline (26). Because of this conflict, we decided to look at the
in vivo steady-state levels of the INO4 mRNA transcript.
Northern analysis demonstrated that the INO4 transcript is
regulated two- to threefold in response to inositol and choline
(Fig. 1A and B). Consistent with the steady-state INO4 mRNA
levels, we found that the Ino4p levels are also regulated in
response to inositol and choline. To eliminate the possibility
that the constitutive expression of the INO4-cat construct was
the result of omitted upstream regulatory sequences, we created additional INO4-cat constructs. Constructs containing sequences 750 and 1,000 bp upstream of the INO4 translational
start site still elicited constitutive CAT activity (Fig. 2). One
possible cause of the discrepancy is that INO4 is regulated at
the level of mRNA stability. INO4 would not be the first gene
in the phospholipid biosynthetic pathway to be regulated at the
level of mRNA stability in response to inositol and choline.
INO1 and CHO2 transcript stability is regulated 50 to 60% by
inositol and choline (J. Yates and J. M. Lopes, unpublished
data). In fact, the threefold regulation seen with the INO4-lacZ
gene may result from mRNA stability, since the INO4-lacZ
construct is a translational fusion (26).
There are currently four methods for measuring mRNA
half-life (21). One method, labeling of cells to steady state (or
by pulse-chase) in vivo, has not been successfully used with
low-abundance transcripts. We attempted to determine the
half-life of the INO4 transcript using thiolutin and by the use of
a yeast temperature-sensitive RNA polymerase (rpb1-1) mutant. Incubation with thiolutin resulted in rapid degradation of
the INO4 transcript, which made it impossible to detect the
transcript by Northern blot hybridization. Experiments using
the rpb1-1 mutant strain yielded the same result as the thiolutin
assay. Moreover, the rpb1-1 mutant is an inositol auxotroph
(23, 24), which would make it difficult to exclude the possibility
that artifacts resulted from the auxotrophy. A final method for
determining mRNA half-life requires placing the gene under
the control of the tightly regulated strong GAL1 promoter
(21). Therefore, the increase in transcript numbers may facilitate detection by Northern blot hybridization. However, in the
case of INO4, this would create gross overexpression of the
INO4 transcript, well beyond physiological levels.
Transcriptional regulation of the phospholipid biosynthetic
genes in response to inositol and choline is mediated by INO2
and INO4 (9). However, INO4 expression does not require
INO2 or INO4 (Fig. 1 and 2). Nevertheless, as is the case with
the coordinately regulated phospholipid biosynthetic genes,
INO4 is constitutively overexpressed in an opi1⌬ strain (Fig.
1A and B). This suggests that OPI1 may regulate both tran-
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Because little is known about elements necessary to direct
expression from a weak promoter in yeast, we determined the
element(s) necessary for INO4 expression. We created various
promoter deletions within the INO4 promoter and fused them
upstream of the cat reporter gene. These constructs did reveal
that the region from ⫺86 to ⫺46 bp upstream of the INO4
translational start site is absolutely necessary for INO4 expression (Fig. 2). To eliminate the possibility of artifacts from the
INO4-cat constructs, we inserted the INO4 promoter deletions
fused upstream of the entire INO4 ORF into YCp50. We
assayed the deletions for the ability to complement the inositol
auxotrophy of an ino4⌬ strain. These experiments supported
the INO4-cat construct data demonstrating that the ⫺58 to
⫺46 region of the INO4 promoter is required for expression.
An S1 nuclease digestion assay demonstrated that the major
INO4 transcriptional start site, along with two minor start sites,
lies within the ⫺58 to ⫺46 region (Fig. 5). Therefore, various
INO4 promoter deletions and the S1 nuclease assay have
shown that INO4 contains an initiator element and no TATA
box. To our knowledge, INO4 is the first yeast gene that requires an initiator element but contains no TATA box. However, this phenomenon is very prevalent in the housekeeping
genes of higher eukaryotes. Housekeeping genes are constitutively expressed genes with promoters that usually do not contain TATA boxes or other regulatory elements (7).
The INO4 promoter study also identified a region that is
required for full INO4-cat expression. Deletion of nucleotides
⫺114 to ⫺86 resulted in an 80 to 90% decrease in cat expression (Fig. 2). However, YCp50-INO4 constructs lacking these
sequences still complemented the inositol auxotrophy and
maintained proper INO1 regulation (Fig. 4). This suggested
that INO4 expression is in excess of what is needed to regulate
the phospholipid biosynthetic genes. This idea is also supported by the fact that overexpression of Ino4p, but not Ino2p,
does not result in elevated levels of the Ino2p/Ino4p/UASINO
complex in mobility shift assays (19).
Sequence analysis illuminated two potential bHLH binding
sites and a TATA-like element. However, the promoter deletions demonstrated that none of these elements were necessary
for INO4-cat expression. Studies with in vitro-transcribed and
-translated Ino2p and Ino4p have shown that they can bind to
the proximal putative INO4 bHLH binding site which most
closely resembles the UASINO element (28). Also, this element, when fused to a CYC1-lacZ reporter, was sufficient to
confer regulation by inositol and choline. However, it has been
observed that certain UASINO elements are functional in the
CYC1-lacZ reporter system (6, 25) but not functional in a
native context (4). We have demonstrated that neither of the
INO4 bHLH promoter elements is required for expression or
regulation (Fig. 2 and 4).
The bHLH region of Ino4p shares homology with the bHLH
region of the mammalian protein Max (20). Max forms heterodimers with Myc, Mad, and Mxi-1 to regulate genes required for cell proliferation and differentiation. Myc levels
increase in cells undergoing proliferation, while Mad levels
increase in cells as they differentiate (1). Max is constitutively
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scription initiation and mRNA stability in response to inositol
and choline.
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